Quris
AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.
About
Technology stack
detected 2026-06-16No comments yet. Be the first to share your take.
What does Quris do?
Quris is a Bio-AI company developing a novel hybrid approach to predict drug safety in humans. Their platform uses machine-learning trained on data from "Patients-on-a-Chip" to identify drug candidates that will safely work, aiming to reduce the high failure rate in clinical trials. Quris serves the pharmaceutical industry by providing an AI safety prediction platform.
How much funding has Quris raised?
Quris has raised a total of $37M in funding. The most recent round on record is Seed.
Where is Quris headquartered?
Quris is headquartered in Tel Aviv, Israel.
When was Quris founded?
Quris was founded in 2019.
What industry does Quris operate in?
Quris operates in Healthcare, Drug Development, Life Sciences, Biotech, Drug Discovery, HealthTech.
How many employees does Quris have?
Quris has approximately 45 people on record.